<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Framlingham Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Framlingham Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=1001010E0&amp;denomIds=10.1.1&amp;selectedTab=summary">Etodolac</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>86</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>713</td>
      <td>0.12</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>7.49</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFh0lEQVR4nO3dW6gVVRzH8e900iLRCqmQCqciSerBLlSmJJUPwoiZ4INE9JT0UG9RE/UQFDQSXeyhILtQdMWHbg5hHYuIKAsKupmVNGAUKdhFlOP138OMcdCzt+fsWWv2nL1+Hxj2OWzP+q3t9rf37DlrxsjMEJEwnNDvCYhIc1R4kYCo8CIBUeFFAqLCiwREhRcJiAovEhAVXiQgKrxIQFR4kYCo8NJ+UaT13444KXyc5ivjNF/nYiwR8Seqe/JMnOavAbOA84F5RZbscjExkf9FkWEW9Xsag8DFO/znwPXARuA6B+OJiCe1C19kydoiSw4Dw8Di+lMSEV9cHrT7ELjB4Xgi4pizwhdZshPYG6d57GpMEXHL9a/lhtG7vEhr+Si8PseLtJTrwn8CLIzTXAt6RFrIaTGLLNkDbAMucTmuiLjh4514E9qtF2klH4XX53iRlvJR+C+BeXGaT/UwtojU4LzwRZYcBL4AFrgeW0Tq8XU0/V1gmaexRaRHvgq/AVgap7nOcBJpES+FL7LkT2AH+vWcSKv4XCDzNnCjx/FFZIJUeJGAeCt8kSVbgWlxmp/jK0NEJsb3mvd30NF6kdbwXXjt1ou0iO/Cbwbmxml+quccERkHr4WvrnW3EVjiM0dExqeJ89bfAO6M03yogSwR6cJ74YssGaY8Rz71nSUi3TV1ZZo7gFviNL+qoTwRGUMjhS+yZDdwK/BinObTm8gUkWM1du25Iks2Ay8DT+madyL90XTxHq4yP47TfG7D2SLBq/2fSfYiTvNlwOPAS8CaIktGGp+ETB76zySd6UvhAeI0nwE8CNwErAeeLbJkS18mI+2mwjvTt8IfEaf5acDNwG3ACOVCnWFgc5El+/s5N2kJFd6Zvhf+iOrqOHMpr3i7GLgC+AX4Cvi6ut1SXTNPQqLCO9Oawh+tWpk3B7is2i6lfEHYTvkC8AOwFfgR2F5kyaE+TVV8U+GdaW3hx1LtBZwHzAMuGrWdDRwEfgN+B3YD/1a3o7c9wP4O24Eu9x0qsmTy/EUNGhXemUlV+G7iND+ZsvizgOnAjOp29DYNmAJMHcc2+s+dOEbkkReJA5QvNmPdjgD7qm301wcAG7Udrvm9izHqjNmLcf9csWZpHt+zIZnoz/WaN9l+rsiSD8Y/ulmtDVhdd4y25AxKxiA9lkHJaDKn2+Zi4c1qB2O0JWdQMprKUUY7czrSEleRgKjwIgFxUfhnHIzRlpxByWgqRxntzOloYI7Si8jxaZdeJCBj/X65oyiKrgWuAXaY2fNRFK0ALqBcAvs95Zr4v8zsiTqTOk7O39V9u83sSR8ZZvZmFEWrgNlmlnl6HJ9RHrXdZmaveMrYCSwCTjezu3rN6JCzHFhiZrcffZ+njOWUC65+MrNXfWRU998L/Gpmr3t6HBdTXrr9GzPb0GtGryb6Dj+/KsAZ1fcXmtkjlEtgE+Ah4CQH8+qYY2YfARkw01dG9aT8UXP8rhnASuAfysUrvjL2AWcCe2tmHJNjZm8BRYc5OM+ovn4UONdXRhRFi4Bva47fNQNYQbkKtC8mWvijP/D7OgBwvJy7gXUeM+ZTvpss8JgxBXiP8vwAXxlzgPsoV/bV1e25dvXvoOM4URQNUT7vT/vKAC4HrsT98z7aTOC5KqdxEzpoV+2qzAd2UZ69Npty9/FnYAuwinKXfm2tSXXPOYvyTLr3zWy9j4zqFZkoilIHu/SdHsd3lNf5O2RmD3jK2AMsBIbM7P5eMzrknEJZwAwYqu7bYWYveMpIKD+CbjKzjT4yzOzTKIpi4GoHu/SdHgeUH7NGzOyxXjN6npuO0ouEQ0fpRQKiwosERIUXCYgKLxIQFV4kICq8SEBUeJGAqPAiAVHhRQKiwosERIUXCch/oXc5vWMJetsAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=1001010E0AAADAD&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Etodolac 600mg modified-release tablets : 86</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0&amp;denomIds=2.6.2&amp;selectedTab=summary">Diltiazem hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1105</td>
      <td>Calcium-channel blockers</td>
      <td>4648</td>
      <td>0.24</td>
      <td>0.05</td>
      <td>0.03</td>
      <td>6.99</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BBAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem 60mg modified-release tablets : 43</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BBABAC&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem Retard 90mg tablets : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BMAAAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 300 XL capsules : 73</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BMABAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 120 XL capsules : 88</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BMACAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 180 XL capsules : 256</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BMADAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Zemtard 240 XL capsules : 281</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BNAAAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 120mg capsules : 124</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BNADAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 300mg capsules : 47</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BNAEBA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 360mg capsules : 34</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFADAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-SR 120mg capsules : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFAEAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-SR 180mg capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BBAEAX&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem LA 200 capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFAIAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 240mg capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFACAT&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-SR 90mg capsules : 13</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BNACAW&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 240mg capsules : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BJABAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Angitil SR 120 capsules : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFAFAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 300mg capsules : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BBADAE&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem LA 300 capsules : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BNABAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Viazem XL 180mg capsules : 25</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFAHAV&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 180mg capsules : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BBACAS&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Tildiem Retard 120mg tablets : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0206020C0BFAGAU&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Adizem-XL 120mg capsules : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0904010T0&amp;denomIds=9.4.1&amp;selectedTab=summary">Gluten free/low protein pasta</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Foods for special diets</td>
      <td>79</td>
      <td>0.13</td>
      <td>0.00</td>
      <td>0.02</td>
      <td>6.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0904010T0BIACAD&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein fusilli : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0904010T0BIAEAD&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein pasta ditali : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0904010T0BIAAAD&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein penne : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0904010T0BIABAD&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Mevalia low protein spaghetti : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0107010N0&amp;denomIds=1.7.1&amp;selectedTab=summary">Lidocaine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>14</td>
      <td>Soothing haemorrhoidal preparations</td>
      <td>14</td>
      <td>1.00</td>
      <td>0.06</td>
      <td>0.15</td>
      <td>6.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0107010N0AAAFAF&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Allantoin 10.25mg / Lidocaine 10.25mg suppositories : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0107010N0BFABAH&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Germoloids ointment : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0107010N0BFACAG&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Germoloids suppositories : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=1302010Z0&amp;denomIds=13.2.1&amp;selectedTab=summary">Chlohexidine gluconate (Emollient)</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Emollients</td>
      <td>90</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.05</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=1302010Z0BBAAAA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Eczmol 1% cream : 1</a></div></td></tr></tbody></table>

        <h2>Prescribing where Framlingham Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0107010Z0&amp;denomIds=1.7.1&amp;selectedTab=summary">Zinc oxide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Soothing haemorrhoidal preparations</td>
      <td>14</td>
      <td>0.00</td>
      <td>0.77</td>
      <td>0.27</td>
      <td>-2.89</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0&amp;denomIds=3.1.2&amp;selectedTab=summary">Tiotropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>65</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>348</td>
      <td>0.19</td>
      <td>0.71</td>
      <td>0.18</td>
      <td>-2.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0AAAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation pdr caps with dev : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0BBAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation pdr caps with HandiHaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0BCAAAD&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Braltus 10microgram inhalation pdr caps with Zonda inhaler : 23</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0BBABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation powder capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0BBADAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln refill cart : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0301020Q0AAABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation powder capsules : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0208020Z0&amp;denomIds=2.8.2&amp;selectedTab=summary">Apixaban</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>160</td>
      <td>Oral anticoagulants</td>
      <td>2613</td>
      <td>0.06</td>
      <td>0.40</td>
      <td>0.14</td>
      <td>-2.38</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0208020Z0AAABAB&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Apixaban 5mg tablets : 145</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0208020Z0AAAAAA&amp;denomIds=2.8.2&amp;selectedTab=summary" target="_blank">Apixaban 2.5mg tablets : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0501030I0&amp;denomIds=5.1.3&amp;selectedTab=summary">Doxycycline hyclate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>102</td>
      <td>Tetracyclines</td>
      <td>317</td>
      <td>0.32</td>
      <td>0.63</td>
      <td>0.14</td>
      <td>-2.29</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0501030I0AAABAB&amp;denomIds=5.1.3&amp;selectedTab=summary" target="_blank">Doxycycline 100mg capsules : 102</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=D83026&amp;numIds=0902012H0&amp;denomIds=9.2.1&amp;selectedTab=summary">Oral rehydration salts</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Oral sodium and water</td>
      <td>9</td>
      <td>0.00</td>
      <td>0.68</td>
      <td>0.31</td>
      <td>-2.20</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>